Charlene Smith-Geater

Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation

Maxwell P. Gold, E. Fraenkel, L. Thompson, 2020, Stem cell reports.

Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice

R. Edwards, L. Thompson, Jie Wu, 2021, bioRxiv.

Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice

R. Edwards, L. Thompson, Jie Wu, 2021, Journal of virology.

An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models

Gene W. Yeo, Maya L. Gosztyla, L. Thompson, 2022, Nature Neuroscience.

CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons

Jesús G. Galaz-Montoya, J. Frydman, Joy Hsu, 2022, bioRxiv.

PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s disease

A. Chakraborty, B. Leavitt, B. Davidson, 2021, Proceedings of the National Academy of Sciences.

BDNF and TRiC-inspired Reagents Rescue Cortical Synaptic Deficits in a Mouse Model of Huntington’s Disease

J. Frydman, L. Thompson, W. Mobley, 2022, bioRxiv.

Huntingtin Maintains Mitochondrial Genome Integrity and Function

A. Chakraborty, L. Ellerby, T. Ashizawa, 2021, SSRN Electronic Journal.